3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
16
INDUSTRY
3
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
3
Tumor-Agnostic
1
Thoracic
1
Dermatologic
1
Conditions
Melanoma
1
Interventions
Nivolumab
5
Interleukin-2
4
pembrolizumab
3
Melphalan
3
Ipilimumab
3
apatinib
2
tremelimumab
1
tislelizumab
1
fludarabine
1
entinostat
1
encorafenib
1
camrelizumab
1
binimetinib
1
Tramadol
1
Technetium
1
Surgical Procedures, Operative
1
Physical Examination
1
Mohs Surgery
1
Microscopy, Confocal
1
Methotrexate
1
Metastasectomy
1
Immunotherapy
1
Ibuprofen
1
Fecal Microbiota Transplantation
1
FMT protocol
1
Dermoscopy
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Immunotherapy
×
Dermatologic
×
Clear all
NCT04242329
2024-01-26
SUMMIST
Vastra Gotaland Region
Phase 2
Withdrawn